Immune Checkpoint Inhibitor Therapy in Oncology Current Uses and Future Directions (JACC: CardioOncology State-of-the-Art Review December 2022)

Immune Checkpoint Inhibitor Therapy in Oncology Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review

This review presents the current landscape of ICIs in oncology, with a focus on important aspects relevant to cardiology.

JACC CardioOncology Editor-in-Chief and CME Editor
Bonnie Ky, MD, MSCE, FACC

Authors
Sean Tan, MBBS
Stephen J. Nicholls, MBBS, PhD

Important Dates

Date of Release: December 20, 2022
Term of Approval/Date of CME/MOC Expiration: December 19, 2023

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered